Indicia Production welcomes investment from Amundi Private Equity Funds

 

Indicia Production welcomes investment from Amundi Private Equity Funds
 

Saint-Genis-l'Argentière, France, June 9, 2015 – Indicia Production, a Contract Manufacturing Organization (CMO) specialized in the formulation and production of sterile liquid media (involving aseptic filling and the manufacture of ready-to-use microbiological media) on behalf of its clients, today announces that Amundi Private Equity Funds (Amundi PEF) has acquired a stake in its capital. This minority interest is expected to support Indicia Production in its external growth, in order to increase its production capabilities. The details of the investment are not being disclosed.
 
Over the last seven years, Indicia Production has doubled its revenue and increased its staff from 30 to 45. The funds raised with Amundi PEF will help to support its expansion, including two acquisitions in France within an 18-month timescale; providing the group with additional production capabilities.
 
Indicia Production's business activity is based on three product families:

  • Ready-to-use microbiology culture environments for a client base; comprising distributors and industry providers of control tests for the pharmaceutical, food processing and cosmetics industries

  • Sterile products and reagents for the pharmaceutical and cosmetics industries

  • Medical devices

"Amundi PEF's investment in Indicia Production is a major milestone in the history of our company, reflecting our ambition to drive Indicia Production forward through both organic growth and acquisitions," said Stéphane Legastelois, chairman of Indicia Group. "Over the course of the next 18 months, we plan to acquire two companies; this will help us to significantly expand our production capabilities."
 
"We are delighted to have invested in Indicia, a high value-added niche pharmaceutical manufacturer," said Vinarom Vilaihongs, partner at Amundi PEF. "We are excited by the prospect of supporting Stéphane Legastelois in his policy of external growth."
 
Dealmakers:

  • For Indicia: Stéphane Legastelois, Marie-Laure Pellotier and Marie-Pierre Varenne

  • For Amundi PEF: Vinarom Vilaihongs and Jean-Christ Ametepe

  • Financial advisers to the company: Clairfield International - Jean-Noël Combassonand Antoine Nouvel

  • Legal advisers to the company: Saône-Rhône Société d'Avocats - Jean-François Chronowski

  • Legal advisers to Amundi PEF: Lamartine Conseil - Cédric Sapede and Camille Ferrat

  • Financial auditors: Odéris - Jean-Albert Bureau and Thomas Corbineau

About Indicia Production
Indicia Production is a CMO specializing in the aseptic filling and sterilizing of liquid products. The company offers a wide range of ready-to-use media for microbiological testing, as well as contract services for the formulation and aseptic filling of liquid media and reagents for the pharmaceutical and cosmetic industries. Indicia's 'microbiology' range is distributed in most European countries by major industry leaders.
Indicia Production is NF EN ISO 9001 and NF EN ISO 13485 certified for microbiological products and sterile liquid medical devices. It also meets the requirements of the GLP (Good Laboratory Practice) conditions for subcontracting within the pharmaceutical industry. Indicia Production is also ECOCERT-certified, a standard created in 2003 for natural and organic cosmetics.
Founded in 2008, Indicia Production is based in Saint-Genis l'Argentière (Rhône, France) and has 45 employees. In 2014, Indicia Production generated a turnover of €6.1 million ($6.8 million).
http://www.indicia.fr/

About Amundi Private Equity Funds
With over €4.8 billion ($5.4 billion) under management as of December 31, 2014, Amundi Private Equity Funds provides its private and institutional clients with a wide range of products devised to meet their needs; offering them access to investment in private equity and infrastructure funds of funds and private equity funds that take direct interests in unlisted companies. With over 40 financial professionals, Amundi PEF provides support to businesses at development and transfer stage. Amundi PEF is a specialist consulting arm of the Amundi Group.
www.amundi-pef.com

 

View the original release and download image

For immediate release

View this email in your browser

Media contact & analysts
Andrew Lloyd & Associates

Juliette dos Santos / Sandra Régnavaque
Tel: +44 1273 675 100 

US + 1 617 202 4491
@ALA_Group 

 

 

 

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.